05/27/2026
Medical Breakthrough: Researchers at the Weizmann Institute of Science have made a global scientific breakthrough after proving for the first time that the human immune system can create long term “immune memory” against cancer tumors through the same mechanism the body uses to remember viruses or traditional vaccines. The discovery opens a major path toward developing a new generation of active cancer vaccines.
To simplify the discovery: until now, most cancer and immunotherapy research focused on T cells, the immune cells that directly attack and destroy tumors. The new study shifts attention to B cells, which are responsible for producing antibodies in the body.
Researchers examined tumor samples and lymph nodes from patients with high grade serous ovarian cancer (HGSOC). To their surprise, they discovered a reservoir of memory B cells in lymph nodes near the tumors.
When scientists recreated the antibodies produced by those cells in the lab, they found that more than one third accurately identified ovarian cancer cells and attacked them powerfully, without harming healthy cells.
If these memory cells are so effective, why do they not destroy cancer immediately?
Researchers identified what they described as the “blocking factor”: a population of macrophages in the lymph nodes that selectively consume B cells during their training stages and prevent their activation.
In other words, cancer appears able to disrupt the immune system’s activation process, leaving these memory cells inactive.
The discovery could make it possible to develop vaccines capable of reactivating the body’s existing “memory” B cells, allowing them to independently produce highly targeted cancer-fighting antibodies against tumors.
